ContractConsultancy Agreement • June 30th, 2017 • Clementia Pharmaceuticals Inc. • Pharmaceutical preparations • Massachusetts
Confidential Information omitted and filed separately with the Securities and Exchange Commission. Five asterisks denote omissions.
COMMERCIAL SPONSORED RESEARCH AGREEMENTCommercial Sponsored Research Agreement • June 30th, 2017 • Clementia Pharmaceuticals Inc. • Pharmaceutical preparations • California
THIS AGREEMENT is entered into this 21sr day of June, 2016 (the “Effective Date”) by Sanford Burnham Prebys Medical Discovery Institute, a California not-for-profit public benefit corporation with an address at 10901 N. Torrey Pines Road, La Jolla, California 92037 (“Institute”) and Clementia Pharmaceuticals, Inc., a privately held biopharmaceutical company with an address at 4150 Sainte-Catherine St West, Suite 550, Montreal, Quebec, H3Z 2Y5, Canada (hereinafter refe1Ted to as “Sponsor”).
AGREEMENT FOR FEE-PER-SERVICEFee-for-Service Agreement • June 30th, 2017 • Clementia Pharmaceuticals Inc. • Pharmaceutical preparations
This Agreement for fee-per-service (this “Agreement’) is effective by and between Clementia Pharmaceuticals, Inc., a privately held biopharmaceutical company with an address at 4150 Sainte-Catherine St. West, Suite 550, Montreal, Quebec, H3Z 2Y5, in the person of Clarissa Desjardins, PhD, CEO (“Clementia”), and Istituto Ortopedico Rizzoli, a public institution with registered office in Bologna, Via di Barbiano n. 1/10 (CAP. 40136), Tax ID and VAT n. 00302030374, in the person of the Chief of SC Amministrazione della Ricerca, Dr. Pierpaola D’Alessandro, [*****], authorized to the signature of this Agreement on behalf of Legal Representative, by IOR Resolution nr. 199 of 2016, Aug 1st (“Rizzoli”/“IOR”) hereafter referred as “Party”/“Parties”.
